Legend Biotech (LEGN) Gross Profit (2019 - 2025)

Legend Biotech (LEGN) has 7 years of Gross Profit data on file, last reported at $242.1 million in Q4 2025.

• In Q4 2025, Gross Profit rose 75.94% year-over-year to $242.1 million; the TTM figure through Dec 2025 stood at $822.9 million (up 71.52% YoY), while the FY2025 annual figure was $823.1 million, up 71.55% from the prior year.
• Gross Profit advanced to $242.1 million in Q4 2025, from $219.7 million in the prior quarter.
• Across five years, Gross Profit topped out at $79.5 billion in Q4 2023 and bottomed at -$13.4 billion in Q1 2021.
• A 5-year average of $3.4 billion and a median of $60.8 million in 2023 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2021 — Gross Profit slumped 268112.76% — and 2023, when it jumped 4390174.38%.
• Year by year, Gross Profit stood at -$13.8 million in 2021, then jumped by 113.1% to $1.8 million in 2022, then jumped by 4390174.38% to $79.5 billion in 2023, then slumped by 99.83% to $137.6 million in 2024, then surged by 75.94% to $242.1 million in 2025.
• The last three Gross Profit figures came in at $242.1 million (Q4 2025), $219.7 million (Q3 2025), and $207.0 million (Q2 2025), per Business Quant data.

Peer Comparison